Researchers identify agent responsible for protection against early stages of atherosclerosis
Monday, December 12, 2011 - 13:00
in Health & Medicine
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol. The findings, which appear on-line in Circulation, may have significant public health implications.